Awarded

INMUNOGLOBULINA HUMANA NORMAL (DOE) INTRAVENOSA AL 5%

Name: INMUNOGLOBULINA HUMANA NORMAL (DOE) INTRAVENOSA AL 5%
Creator: HOSPITAL CLINICO SAN CARLOS
Published: 2026-01-23
License: https://ted.europa.eu/en/simap/legal-notice

Track this recordFree account — get alerted when a contract here runs out.

Buyer: HOSPITAL CLINICO SAN CARLOS
Winners: Octapharma, S.A.
Contract value: €352,000
Bids received: 1
Published: 23 Jan 2026
Awarded: 20 Jan 2026
Contract start: 20 Jan 2026
Contract end: 21 Jan 2027estimated
Sector: Medical equipment and pharmaceuticals
Region: Madrid
Source: Original notice on TED (55408-2026)

More awards from this buyer

Awarded	Buyer	Winner	Contract value	Published
SUMINISTRO, INSTALACIÓN Y PUESTA EN FUNCIONAMIENTO DE LA INFRAESTRUCTURA SUSPENDIDA Y DE LOS SISTEMAS DE INTEGRACIÓN PARA EL NUEVO BLOQUE QUIRÚRGICO DE CIRUGÍA MAYOR AMBULATORIA, EN EL HOSPITAL CLÍNICO SAN CARLOS DE MADRID	HOSPITAL CLINICO SAN CARLOS	PRIM, S.A.	€2,334,896	16 Sept 2026
RYSTIGGO 140 MG/ML SOLUCION INYECTABLE, 1 vial de 3 ml	HOSPITAL CLINICO SAN CARLOS	UCB PHARMA S.A.	€296,836	3 Sept 2026
RYSTIGGO 140 MG/ML SOLUCION INYECTABLE, 1 vial de 2 ml	HOSPITAL CLINICO SAN CARLOS	UCB PHARMA S.A.	€65,937	3 Sept 2026
BRIVIACT 10 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION 5 ML	HOSPITAL CLINICO SAN CARLOS	UCB PHARMA S.A.	€69,930RV	3 Sept 2026
BRIVIACT 10 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION 5 ML	HOSPITAL CLINICO SAN CARLOS	UCB PHARMA S.A.	€69,930RV	3 Sept 2026
ABILIFY MAINTENA 720 MG POLVO Y DISOLVENTE PARA SUSPENSION DE LIBERACION PROLONGADA	HOSPITAL CLINICO SAN CARLOS	OTSUKA PHARMACEUTICAL S.A.	€60,737	1 Sept 2026